AS
REGN icon

Altshuler Shaham’s Regeneron Pharmaceuticals REGN Stock Holding History

Altshuler Shaham’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18
Closed -$18.9K – 411
2024
Q3 		$18.9K Buy
+18
New +$20K ﹤0.01% 196
2023
Q3 		– Sell
-412
Closed -$296K – 336
2023
Q2 		$296K Sell
412
-132
-24% -$102K 0.01% 95
2023
Q1 		$447K Sell
544
-106
-16% -$79.9K 0.01% 78
2022
Q4 		$469K Sell
650
-276
-30% -$204K 0.02% 67
2022
Q3 		$641K Sell
926
-285
-24% -$179K 0.02% 87
2022
Q2 		$716K Buy
1,211
+1,062
+713% +$690K 0.01% 90
2022
Q1 		$104K Sell
149
-47
-24% -$29.7K ﹤0.01% 262
2021
Q4 		$124K Sell
196
-149,984
-100% -$92.2M ﹤0.01% 314
2021
Q3 		$146K Buy
150,180
+149,259
+16,206% +$92.7M ﹤0.01% 283
2021
Q2 		$515K Buy
921
+127
+16% +$64.3K ﹤0.01% 198
2021
Q1 		$376K Sell
794
-39
-5% -$19K ﹤0.01% 151
2020
Q4 		$402K Sell
833
-1,210
-59% -$653K 0.01% 127
2020
Q3 		$1.14M Buy
2,043
+1,273
+165% +$772K 0.03% 72
2020
Q2 		$480K Buy
770
+692
+887% +$393K 0.01% 104
2020
Q1 		$38K Sell
78
-3,327
-98% -$1.37M ﹤0.01% 198
2019
Q4 		$1.28M Buy
+3,405
New +$1.15M 0.04% 70
2019
Q3 		– Sell
-4,424
Closed -$1.39M – 537
2019
Q2 		$1.39M Buy
4,424
+4,379
+9,731% +$1.46M 0.06% 62
2019
Q1 		$18K Buy
45
+24
+114% +$9.88K ﹤0.01% 195
2018
Q4 		$8K Buy
+21
New +$7.69K ﹤0.01% 208
2018
Q1 		– Sell
-5,731
Closed -$2.15M – 221
2017
Q4 		$2.15M Buy
+5,731
New +$2.32M 0.31% 28

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Altshuler Shaham's REGN Position: Q4 2024 in Review

Altshuler Shaham sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 18 shares — an estimated $18.9K sold.

Altshuler Shaham first reported a position in REGN in Q4 2017 and held it in 20 quarters. The position peaked at $2.15M in Q4 2017. 1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • Altshuler Shaham reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Altshuler Shaham sold 18 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $18.9K.
  • Altshuler Shaham first reported a position in Regeneron Pharmaceuticals in Q4 2017 and held it in 20 quarters.
  • Altshuler Shaham's Regeneron Pharmaceuticals position peaked at $2.15M in Q4 2017.
  • 1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on Altshuler Shaham's 13F filing for Q4 2024, filed 13 Feb 2025.